MorphoSys AG ADR buy Stakeholder
Start price
05.08.20
/
50%
€29.00
Target price
04.11.21
-
Performance (%)
-62.07%
End price
17.08.21
€11.00
Summary
This prediction ended on 17.08.21 with a price of €11.00. The BUY prediction by Stakeholder for MorphoSys AG ADR performed very badly with a performance of -62.07%. Stakeholder has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG ADR | - | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by Stakeholder for this prediction
In the thread Morphosys AG diskutieren
Zulassung des Krebsmedikamentes Monjuvi in den USA